• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Antibiotic Resistance: Market Developments, Growth Areas and Opportunities 2014 - Product Image

Antibiotic Resistance: Market Developments, Growth Areas and Opportunities 2014

  • Published: January 2014
  • Region: Global
  • 176 Pages
  • BioPharm Reports (VennBio Ltd.)

Threats posed by the global increase in antibiotic resistant bacterial strains continue to cause alarm, and some observers suggest that this problem is threatening to take societies back to a pre-antibiotic era. However, the last five years have seen important changes in practices, innovation and attitudes, in response to this growing threat. Biopharm Reports has recently carried out a global market study of antibiotic resistance, to identify the changing developments and management strategies that are taking place, and the opportunities these offer to developers in this field.

Biopharm Reports has carried out a global market study of antibiotics resistance, to identifying the changes that are taking place in the ‘antibiotic resistance market’ and the opportunities these present to developers in this field. This global study involved the participation of 652 clinicians, scientists, researchers and Government officials in 80 countries and provides a comprehensive overview of current and evolving practices, developments and strategies and their importance in the combating and management of antibiotic resistance.

This report provides a wealth of information for READ MORE >

1. General
1.1 Study description
1.2 Participants
1.3 Countries
1.4 Organisations

2. Clinical
2.1 Top Therapeutic Areas
2.2 Top Infection Types
2.3 Differentiating Bacterial and Viral Infections
2.3.1 Current patients
2.3.2 Preferred distinguishing tests
2.3.3 Suppliers and instrumentation
2.3.4 Test costs per patient
2.3.5 Test time
2.3.6 Future distinction between bacterial and viral infections
2.3.7 Future patients
2.3.8 Future tests and instrumentation
2.3.9 Future preferred suppliers
2.4 Causal Bacteria
2.4.1 Identification methods
2.4.2 Current patients
2.4.3 Laboratory identification methods
2.4.4 Preferred tests and instrumentation
2.4.5 Preferred suppliers
2.4.6 Test costs per patient
2.4.7 Test time
2.4.8 Future identification of causal bacterial types
2.4.9 Future patients
2.4.10 Future bacterial identification methods
2.4.11 Tests and instrumentation
2.4.12 Preferred suppliers
2.5 Antibiotic Resistance Genes
2.5.1 Current patients
2.5.2 Preferred tests and instrumentation
2.5.3 Preferred suppliers
2.5.4 Testing costs
2.5.5 Test time
2.5.6 Future identification of resistance genes
2.5.7 Future patients
2.5.8 Antibiotic resistance gene tests and instrumentation
2.5.9 Future suppliers
2.6 Integrated Programmes
2.6.1 Current programmes
2.6.2 Names and locations
2.6.3 Future programmes
2.6.4 Names and locations
2.7 Antimicrobial stewardship programmes
2.7.1 Current programmes
2.7.2 Names and locations
2.7.3 Future programmes
2.7.4 Names and locations
2.7.5 Future antimicrobial stewardship programmes
2.7.6 Name and location
2.8 Gram negative bacteria
2.9 Gram positive bacteria
2.10 Other bacteria
2.11 Antibiotics against Gram negative bacteria
2.12 Antibiotics against Gram positive bacteria
2.13 Antibiotics against other bacteria
2.14 Treatment costs
2.15 Single antibiotics or combinations
2.16 Innovation
2.17 Barriers
2.18 Initiatives

3. Laboratory
3.1 Purpose
3.2 Top three therapeutic areas
3.3 Antibiotic source
3.4 Gram negative bacteria
3.5 Gram positive bacteria
3.6 Other bacteria
3.7 Companion diagnostics
3.8 Current Identification methods
3.8.1 Preferred current products and suppliers
3.9 Future identification methods
3.9.1 Preferred products and supplier
3.10 Antibiotics against Gram negative bacteria
3.11 Antibiotics against Gram positive bacteria
3.12 Antibiotics against other bacteria
3.13 Novel antibiotic combinations
3.14 Single antibiotics or combinations
3.15 Integrated programmes
3.15.1 Current programmes
3.15.2 Names and locations
3.15.3 Future programmes
3.15.4 Names and locations
3.16 Current programme
3.17 Future integrated programme
3.18 Name and location
3.19 Antimicrobial stewardship programmes
3.19.1 Current programmes
3.19.2 Names and locations
3.19.3 Future programmes
3.19.4 Names and locations
3.20 Innovation
3.21 Barriers
3.22 Initiatives

4. Diagnostics
4.1 Therapeutic areas
4.2 Source of antibiotics
4.3 Gram negative bacteria
4.4 Gram positive bacteria
4.5 Other bacteria
4.6 Companion diagnostics
4.7 Bacterial and viral infections
4.8 Future tests for distinguishing bacterial and viral infections
4.9 Identifying causal bacteria
4.10 laboratory identification methods
4.10.1 Preferred products and suppliers
4.11 Future identification of causal bacterial types
4.11.1 Preferred products and suppliers
4.12 Integrated programmes
4.12.1 Current programmes
4.12.2 Names and locations
4.12.3 Future programmes
4.12.4 Names and locations
4.13 Antimicrobial stewardship programmes
4.13.1 Current programmes
4.13.2 Names and locations
4.13.3 Future programmes
4.13.4 Names and locations
4.14 Innovation
4.15 Barriers
4.16 Initiatives

Market findings from this study are based on 'real world' laboratory data, provided by research scientists and clinicians who work routinely on the challenges posed by antibiotic resistance.

This study investigated 117 market areas covering current activities, recent developments and trends, anticipated future growth, shrinkage and opportunities. Its findings provide market information on current and developing activities to combat antibiotic resistance and assist companies selling into these markets to respond to laboratory users’ current needs and their future plans.

Biopharm Reports specialises in carrying out market studies of techniques and applications used in life science laboratories and clinics. All our studies involve the participation of scientists and clinicians and investigate in-depth, key areas of their current use of specialised laboratory techniques, and their plans for using these techniques over the next three years.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos